BioGaia Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de BioGaia de 21.2% y 14.7% respectivamente, mientras que el BPA crecerá en un 21.2% al año.

Información clave

21.2%

Tasa de crecimiento de los beneficios

21.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs	49.5%
Tasa de crecimiento de los ingresos	14.7%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	11 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Oct 29

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Previsiones de crecimiento de beneficios e ingresos

OM:BIOG B - Estimaciones futuras de los analistas y datos financieros pasados (SEK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	1,639	434	N/A	N/A	1
12/31/2024	1,445	350	N/A	N/A	1
9/30/2024	1,356	337	365	393	N/A
6/30/2024	1,369	402	360	394	N/A
3/31/2024	1,300	371	323	379	N/A
12/31/2023	1,297	365	377	426	N/A
9/30/2023	1,273	437	361	396	N/A
6/30/2023	1,213	415	311	342	N/A
3/31/2023	1,186	413	310	324	N/A
12/31/2022	1,104	374	301	319	N/A
9/30/2022	1,036	273	262	284	N/A
6/30/2022	952	246	286	305	N/A
3/31/2022	867	222	263	273	N/A
12/31/2021	785	196	215	222	N/A
9/30/2021	767	196	215	220	N/A
6/30/2021	725	164	201	208	N/A
3/31/2021	766	188	177	190	N/A
12/31/2020	747	180	205	221	N/A
9/30/2020	767	194	155	184	N/A
6/30/2020	802	211	155	189	N/A
3/31/2020	780	193	147	185	N/A
12/31/2019	768	187	109	148	N/A
9/30/2019	770	192	133	160	N/A
6/30/2019	778	205	152	174	N/A
3/31/2019	756	207	161	176	N/A
12/31/2018	742	215	170	183	N/A
9/30/2018	702	206	211	223	N/A
6/30/2018	675	197	N/A	192	N/A
3/31/2018	631	181	N/A	181	N/A
12/31/2017	615	181	N/A	223	N/A
9/30/2017	584	179	N/A	201	N/A
6/30/2017	562	172	N/A	210	N/A
3/31/2017	542	163	N/A	198	N/A
12/31/2016	535	160	N/A	148	N/A
9/30/2016	500	138	N/A	115	N/A
6/30/2016	480	129	N/A	86	N/A
3/31/2016	478	130	N/A	108	N/A
12/31/2015	483	138	N/A	118	N/A
9/30/2015	500	130	N/A	100	N/A
6/30/2015	474	119	N/A	67	N/A
3/31/2015	432	97	N/A	55	N/A
12/31/2014	482	147	N/A	124	N/A
9/30/2014	451	146	N/A	126	N/A
6/30/2014	433	145	N/A	163	N/A
3/31/2014	426	142	N/A	167	N/A
12/31/2013	316	62	N/A	78	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (21.2% al año) de BIOG B es superior a la tasa de ahorro (1.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (21.2% al año) de BIOG B crezcan más rápidamente que el mercado Swedish (15.4% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de BIOG B crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (14.7% al año) de BIOG B crezcan más rápidamente que los del mercado Swedish (0.04% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 14.7% al año) de BIOG B crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de BIOG B se prevé que sea elevada dentro de 3 años.

BioGaia Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.1% to kr150

Price target increased by 22% to kr140

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Price target increased by 9.1% to kr120

Price target decreased to kr102

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Recent updates

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Third quarter 2024 earnings released: EPS: kr0.36 (vs kr1.01 in 3Q 2023)

BioGaia AB (publ) to Report Q2, 2025 Results on Jul 18, 2025

Price target increased by 7.1% to kr150

Vice President of Marketing recently sold kr407k worth of stock

Executive VP & CFO recently sold kr11m worth of stock

Vice President of Marketing exercised options to buy kr579k worth of stock.

Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.80 in 2Q 2023)

BioGaia AB (publ) to Report Fiscal Year 2024 Results on Feb 12, 2025

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Third quarter 2021 earnings released